170 related articles for article (PubMed ID: 30844084)
1. Multi-trajectories of antidepressant and antipsychotic use: a 11-year naturalistic study in a community-based sample.
Verdoux H; Pambrun E; Tournier M; Cortaredona S; Verger P
Acta Psychiatr Scand; 2019 Jun; 139(6):536-547. PubMed ID: 30844084
[TBL] [Abstract][Full Text] [Related]
2. Trajectories of Antipsychotic Drug Use Over 10 Years in a French Community-Based Sample of Persons Aged 50 and Older.
Verdoux H; Pambrun E; Tournier M; Cortaredona S; Verger P
Am J Geriatr Psychiatry; 2019 Jan; 27(1):73-83. PubMed ID: 30442530
[TBL] [Abstract][Full Text] [Related]
3. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation.
Verdoux H; Pambrun E; Tournier M; Bezin J; Pariente A
Schizophr Res; 2016 Dec; 178(1-3):58-63. PubMed ID: 27624680
[TBL] [Abstract][Full Text] [Related]
5. Transition in care in persons with antidepressant prescription in naturalistic conditions.
Verdoux H; Gaudron Y; Tournier M
Fam Pract; 2011 Aug; 28(4):400-5. PubMed ID: 21398386
[TBL] [Abstract][Full Text] [Related]
6. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study.
Hu J; McMillan SS; Theodoros T; Collins JC; El-Den S; O'Reilly CL; Wheeler AJ
BMC Psychiatry; 2022 Nov; 22(1):705. PubMed ID: 36380352
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013.
Verdoux H; Pambrun E; Cortaredona S; Tournier M; Verger P
Eur Child Adolesc Psychiatry; 2015 Oct; 24(10):1181-91. PubMed ID: 25564132
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study.
Brett J; Daniels B; Karanges EA; Buckley NA; Schneider C; Nassir A; McLachlan AJ; Pearson SA
Br J Clin Pharmacol; 2017 Nov; 83(11):2581-2588. PubMed ID: 28689375
[TBL] [Abstract][Full Text] [Related]
10. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010.
Ilyas S; Moncrieff J
Br J Psychiatry; 2012 May; 200(5):393-8. PubMed ID: 22442100
[TBL] [Abstract][Full Text] [Related]
11. Interprovincial Variation in Antipsychotic and Antidepressant Prescriptions Dispensed in the Canadian Pediatric Population.
Arora N; Knowles S; Gomes T; Mamdani MM; Juurlink DN; Carlisle C; Tadrous M
Can J Psychiatry; 2016 Dec; 61(12):758-765. PubMed ID: 27310244
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
[TBL] [Abstract][Full Text] [Related]
13. [Antidepressant and antipsychotic drug prescribing in Lombardy].
Percudani M; Barbui C; Fortino I; Tansella M; Petrovich L
Epidemiol Psichiatr Soc; 2006; 15(1):59-70. PubMed ID: 16584104
[TBL] [Abstract][Full Text] [Related]
14. Incident users of antipsychotics: who are they and how do they fare?
Baandrup L; Kruse M
Soc Psychiatry Psychiatr Epidemiol; 2016 Apr; 51(4):505-12. PubMed ID: 26409887
[TBL] [Abstract][Full Text] [Related]
15. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
16. [Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers].
Verdoux H; Gaudron Y; Auleley GR; Deligne J; Blum-Boisgard C; Thiébaut A; Tournier M
Encephale; 2013 May; 39 Suppl 1():S22-8. PubMed ID: 23246328
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009-2012: focus on children, adolescents and prescriber specialty.
Karanges EA; Stephenson CP; McGregor IS
Aust N Z J Psychiatry; 2014 Oct; 48(10):917-31. PubMed ID: 24927734
[TBL] [Abstract][Full Text] [Related]
18. Prescription patterns for psychotropic drugs in cancer patients; a large population study in the Netherlands.
Ng CG; Boks MP; Smeets HM; Zainal NZ; de Wit NJ
Psychooncology; 2013 Apr; 22(4):762-7. PubMed ID: 22351591
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
20. Description of long-term polypharmacy among schizophrenia outpatients.
Suokas JT; Suvisaari JM; Haukka J; Korhonen P; Tiihonen J
Soc Psychiatry Psychiatr Epidemiol; 2013 Apr; 48(4):631-8. PubMed ID: 23007295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]